Works matching IS 15430790 AND DT 2022 AND VI 20 AND IP 2
Results: 7
Current and Emerging Immunotherapies for Recurrent Cervical Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 2, p. 108
- By:
- Publication type:
- Article
The Role of Minimal Residual Disease in Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 2, p. 97
- By:
- Publication type:
- Article
Evolving Management of Patients With Double-Hit Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 2, p. 89
- By:
- Publication type:
- Article
Sequencing Strategies in the Management of Metastatic Colorectal Cancer With HER2 Amplification.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 2, p. 86
- By:
- Publication type:
- Article
When to Use Germline Genetic Testing in Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 2, p. 78
- By:
- Publication type:
- Article
Barriers to Adherence to Oral Drug Regimens in Oncology and Strategies for Improvement.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 2, p. 75
- By:
- Publication type:
- Article
An Open Letter to Dr Fauci.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 2, p. 67
- By:
- Publication type:
- Article